Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diterpenes | 14 | 2023 | 83 | 3.110 |
Why?
|
| Neuroprotective Agents | 10 | 2022 | 231 | 2.420 |
Why?
|
| Receptors, Nicotinic | 10 | 2012 | 91 | 1.950 |
Why?
|
| Cholinesterase Inhibitors | 4 | 2015 | 41 | 1.460 |
Why?
|
| Isoflurophate | 3 | 2015 | 10 | 1.170 |
Why?
|
| Nicotinic Antagonists | 5 | 2012 | 28 | 1.120 |
Why?
|
| Hippocampus | 10 | 2022 | 546 | 1.110 |
Why?
|
| Ion Channel Gating | 7 | 2008 | 81 | 0.760 |
Why?
|
| Brain | 11 | 2015 | 1268 | 0.600 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2023 | 1534 | 0.600 |
Why?
|
| Electric Organ | 5 | 1999 | 18 | 0.580 |
Why?
|
| Nicotine | 4 | 2022 | 238 | 0.560 |
Why?
|
| Animals | 44 | 2023 | 14307 | 0.550 |
Why?
|
| Neurosciences | 1 | 2015 | 23 | 0.540 |
Why?
|
| Rats | 25 | 2023 | 3261 | 0.530 |
Why?
|
| Synapses | 2 | 2015 | 173 | 0.520 |
Why?
|
| Research Personnel | 1 | 2015 | 133 | 0.500 |
Why?
|
| Acetylcholinesterase | 5 | 2015 | 53 | 0.490 |
Why?
|
| Research | 1 | 2015 | 159 | 0.490 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2013 | 32 | 0.460 |
Why?
|
| GABA Antagonists | 1 | 2012 | 25 | 0.450 |
Why?
|
| Phencyclidine | 4 | 2000 | 17 | 0.450 |
Why?
|
| Paraoxon | 2 | 2015 | 9 | 0.440 |
Why?
|
| Brain Injuries | 1 | 2014 | 104 | 0.440 |
Why?
|
| Carbachol | 3 | 2009 | 18 | 0.440 |
Why?
|
| Spermine | 7 | 1997 | 64 | 0.440 |
Why?
|
| Torpedo | 7 | 1999 | 41 | 0.420 |
Why?
|
| Behavior, Animal | 3 | 2009 | 304 | 0.420 |
Why?
|
| Muscle Proteins | 3 | 1999 | 48 | 0.410 |
Why?
|
| Acetylcholine | 5 | 2004 | 68 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 3 | 1999 | 338 | 0.340 |
Why?
|
| Anthozoa | 1 | 2009 | 24 | 0.340 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 103 | 0.330 |
Why?
|
| Cholinergic Agonists | 1 | 2008 | 7 | 0.320 |
Why?
|
| Myoblasts | 1 | 2008 | 25 | 0.320 |
Why?
|
| Brain Ischemia | 2 | 2023 | 179 | 0.320 |
Why?
|
| Putrescine | 4 | 1993 | 25 | 0.320 |
Why?
|
| Atropine | 3 | 2015 | 12 | 0.290 |
Why?
|
| Xenopus laevis | 7 | 2007 | 73 | 0.270 |
Why?
|
| Receptors, Cholinergic | 4 | 1996 | 28 | 0.270 |
Why?
|
| Patch-Clamp Techniques | 5 | 2008 | 214 | 0.260 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2014 | 34 | 0.260 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2000 | 92 | 0.260 |
Why?
|
| Pralidoxime Compounds | 2 | 2015 | 5 | 0.240 |
Why?
|
| Nicotinic Agonists | 1 | 2004 | 68 | 0.240 |
Why?
|
| Environment | 5 | 1990 | 130 | 0.230 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2013 | 12 | 0.220 |
Why?
|
| Memantine | 1 | 2022 | 5 | 0.220 |
Why?
|
| Parasympatholytics | 2 | 2011 | 6 | 0.220 |
Why?
|
| Neurons | 4 | 2015 | 1130 | 0.220 |
Why?
|
| Eflornithine | 3 | 1993 | 18 | 0.220 |
Why?
|
| N-Methylaspartate | 3 | 2022 | 55 | 0.220 |
Why?
|
| Cerebral Cortex | 5 | 1993 | 274 | 0.210 |
Why?
|
| Male | 16 | 2023 | 18870 | 0.210 |
Why?
|
| Cnidaria | 2 | 2007 | 8 | 0.200 |
Why?
|
| Oocytes | 5 | 2004 | 143 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 984 | 0.200 |
Why?
|
| Stroke | 2 | 2015 | 274 | 0.190 |
Why?
|
| Exploratory Behavior | 5 | 1994 | 72 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2015 | 562 | 0.180 |
Why?
|
| Ion Channels | 2 | 1999 | 69 | 0.180 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1997 | 16 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 56 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 257 | 0.160 |
Why?
|
| Membrane Potentials | 3 | 2008 | 213 | 0.150 |
Why?
|
| Biogenic Polyamines | 3 | 1993 | 7 | 0.150 |
Why?
|
| Action Potentials | 4 | 2013 | 219 | 0.150 |
Why?
|
| Gangliosides | 1 | 1996 | 7 | 0.150 |
Why?
|
| Mice | 7 | 2015 | 5668 | 0.140 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 99 | 0.140 |
Why?
|
| Cholinergic Antagonists | 1 | 1995 | 8 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 137 | 0.140 |
Why?
|
| Bradykinin | 2 | 2013 | 22 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 376 | 0.140 |
Why?
|
| Amino Acid Sequence | 5 | 2000 | 1124 | 0.130 |
Why?
|
| Pyridostigmine Bromide | 1 | 2015 | 5 | 0.130 |
Why?
|
| Peptides | 1 | 1997 | 308 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 1490 | 0.120 |
Why?
|
| Spermidine | 3 | 1990 | 31 | 0.120 |
Why?
|
| Seizures | 1 | 2014 | 67 | 0.120 |
Why?
|
| Cell Line | 5 | 2015 | 1289 | 0.120 |
Why?
|
| Cell Death | 1 | 2014 | 260 | 0.110 |
Why?
|
| Terpenes | 1 | 1993 | 28 | 0.110 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 7 | 0.110 |
Why?
|
| Sodium Channels | 1 | 1993 | 63 | 0.110 |
Why?
|
| Female | 10 | 2023 | 19873 | 0.110 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2012 | 5 | 0.110 |
Why?
|
| Polyamines | 1 | 1992 | 28 | 0.110 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 76 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 818 | 0.100 |
Why?
|
| Tromethamine | 2 | 1989 | 5 | 0.100 |
Why?
|
| Cholinesterase Reactivators | 1 | 2011 | 4 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1300 | 0.100 |
Why?
|
| Pheochromocytoma | 1 | 2010 | 11 | 0.100 |
Why?
|
| Rats, Inbred Strains | 5 | 1994 | 132 | 0.090 |
Why?
|
| Electric Stimulation | 3 | 2008 | 177 | 0.090 |
Why?
|
| Planarians | 1 | 2009 | 1 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2013 | 751 | 0.090 |
Why?
|
| Binding Sites | 3 | 2007 | 597 | 0.090 |
Why?
|
| RNA | 3 | 1987 | 234 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 1989 | 63 | 0.080 |
Why?
|
| Motor Activity | 2 | 2009 | 393 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 283 | 0.080 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 37 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 87 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2008 | 137 | 0.080 |
Why?
|
| Receptors, GABA-A | 1 | 2007 | 60 | 0.080 |
Why?
|
| Kinetics | 2 | 1999 | 650 | 0.080 |
Why?
|
| Brain Chemistry | 3 | 2012 | 134 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 249 | 0.070 |
Why?
|
| Cebidae | 1 | 1985 | 4 | 0.070 |
Why?
|
| Saimiri | 1 | 1985 | 6 | 0.070 |
Why?
|
| Neurotoxins | 2 | 1995 | 52 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 1987 | 102 | 0.070 |
Why?
|
| Object Attachment | 1 | 1985 | 24 | 0.070 |
Why?
|
| Bungarotoxins | 2 | 1997 | 21 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2004 | 162 | 0.060 |
Why?
|
| Organ Size | 6 | 1994 | 148 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 131 | 0.060 |
Why?
|
| Humans | 4 | 2015 | 34853 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2003 | 47 | 0.060 |
Why?
|
| Organ Specificity | 2 | 1993 | 123 | 0.060 |
Why?
|
| Cell Membrane | 2 | 1996 | 360 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 756 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1317 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 485 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 54 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2000 | 87 | 0.050 |
Why?
|
| Social Environment | 3 | 1994 | 186 | 0.050 |
Why?
|
| Point Mutation | 1 | 1999 | 88 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 122 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 175 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 168 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1999 | 257 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 1999 | 97 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 286 | 0.040 |
Why?
|
| Color | 2 | 1990 | 19 | 0.040 |
Why?
|
| Calcium Channels | 2 | 1995 | 72 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1997 | 6 | 0.040 |
Why?
|
| Tritium | 1 | 1997 | 48 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 33 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1997 | 61 | 0.040 |
Why?
|
| Administration, Topical | 1 | 1997 | 39 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 1997 | 75 | 0.040 |
Why?
|
| Snake Venoms | 1 | 1977 | 2 | 0.040 |
Why?
|
| Cytotoxins | 1 | 1977 | 10 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 1995 | 141 | 0.040 |
Why?
|
| G(M2) Ganglioside | 1 | 1996 | 3 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 7 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 1996 | 37 | 0.040 |
Why?
|
| Glucose | 2 | 2015 | 217 | 0.040 |
Why?
|
| Cations | 1 | 1995 | 44 | 0.030 |
Why?
|
| Fatty Acids | 1 | 1996 | 118 | 0.030 |
Why?
|
| Calcium | 2 | 1995 | 445 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 55 | 0.030 |
Why?
|
| Injections | 1 | 1974 | 35 | 0.030 |
Why?
|
| Metabolome | 1 | 2015 | 47 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 69 | 0.030 |
Why?
|
| Electrophysiology | 3 | 2007 | 130 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1995 | 350 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 117 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1995 | 201 | 0.030 |
Why?
|
| DNA | 2 | 1987 | 549 | 0.030 |
Why?
|
| Tetracaine | 1 | 1993 | 4 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 1994 | 160 | 0.030 |
Why?
|
| Cnidarian Venoms | 1 | 1993 | 23 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2012 | 14 | 0.030 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 6 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 1973 | 98 | 0.030 |
Why?
|
| Catheterization | 1 | 2012 | 23 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 61 | 0.030 |
Why?
|
| Magnesium | 1 | 1993 | 95 | 0.030 |
Why?
|
| Rubidium | 1 | 1992 | 6 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 2012 | 6 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2012 | 122 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1992 | 103 | 0.030 |
Why?
|
| Ligands | 1 | 1993 | 317 | 0.030 |
Why?
|
| Chemistry | 2 | 1989 | 17 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1989 | 53 | 0.030 |
Why?
|
| Rana pipiens | 2 | 1989 | 58 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1993 | 467 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 224 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 445 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1442 | 0.020 |
Why?
|
| Cyclohexylamines | 1 | 1990 | 12 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1990 | 58 | 0.020 |
Why?
|
| Body Weight | 3 | 1987 | 404 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2010 | 84 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 834 | 0.020 |
Why?
|
| Protein Binding | 1 | 1993 | 913 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1990 | 33 | 0.020 |
Why?
|
| Cerebellum | 1 | 1990 | 69 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 639 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 468 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 600 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 569 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1990 | 159 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2128 | 0.020 |
Why?
|
| Androstenols | 1 | 2007 | 2 | 0.020 |
Why?
|
| Pregnanolone | 1 | 2007 | 3 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 85 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 117 | 0.020 |
Why?
|
| Succinates | 1 | 1985 | 3 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1985 | 33 | 0.020 |
Why?
|
| Social Behavior | 1 | 1985 | 124 | 0.020 |
Why?
|
| Evoked Potentials | 2 | 1995 | 83 | 0.020 |
Why?
|
| Mutation | 1 | 2007 | 1023 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1980 | 42 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 1980 | 58 | 0.010 |
Why?
|
| Social Isolation | 2 | 1994 | 27 | 0.010 |
Why?
|
| Arousal | 1 | 1979 | 82 | 0.010 |
Why?
|
| Models, Structural | 1 | 1977 | 8 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1977 | 150 | 0.010 |
Why?
|
| Sensory Deprivation | 1 | 1974 | 6 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1974 | 34 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1994 | 5 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1974 | 52 | 0.010 |
Why?
|
| Mental Recall | 1 | 1994 | 73 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 1994 | 54 | 0.010 |
Why?
|
| Nucleus Accumbens | 1 | 1994 | 80 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1994 | 108 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1973 | 38 | 0.010 |
Why?
|
| Culture Media | 1 | 1973 | 84 | 0.010 |
Why?
|
| Research Design | 1 | 1974 | 292 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1994 | 333 | 0.010 |
Why?
|
| Water | 1 | 1974 | 283 | 0.010 |
Why?
|
| Time Factors | 1 | 1974 | 1681 | 0.010 |
Why?
|
| Motor Endplate | 1 | 1985 | 3 | 0.000 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1985 | 2 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1985 | 8 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1985 | 25 | 0.000 |
Why?
|
| Pituitary Gland | 1 | 1970 | 59 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1970 | 207 | 0.000 |
Why?
|